A 1-year Study in Adolescents to Assess the Long-term Safety of Almotriptan Malate When Treating Their Migraine Headaches
Status:
Completed
Trial end date:
2007-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the long-term safety of almotriptan malate (a
migraine headache medication) in the treatment of migraine headaches in adolescents for up to
one year.